Trials / Terminated
TerminatedNCT05842343
Food Intake and IgA Microbiota in Anorexia Nervosa
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Anorexia nervosa is characterized by intestinal dysbiosis, related to the feeding behavior impairment presented by these patients. Pathophysiologic hypotheses are involving the trouble of the microbiota-gut-brain axis in the field of mental diseases.
Detailed description
Anorexia nervosa is characterized by intestinal dysbiosis, related to the feeding behavior impairment presented by these patients. Here we aim to characterize the IgA-coated fraction of bacteria from the intestinal microbiota, linked to the regulation of the mucosal immune system and the epithelium physiology. Abnormalities of this microbiota are reported in inflammatory bowel disease and are associated to immune trouble. As food intake plays a key role in shaping microbiota, we aim to correlate data from IgA microbiota to food intake specificity, and to anorexia nervosa phenotypes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Stool sample | Purification by affinity of the IgA coated bacteria from a fecal solution. Genomic analysis of the bacteria for diversity and richness |
| OTHER | Food intake evaluation | Measure (by survey) of food group intake for : lipids /proteins / fibers / carbohydrates |
Timeline
- Start date
- 2023-10-13
- Primary completion
- 2023-11-28
- Completion
- 2024-02-02
- First posted
- 2023-05-06
- Last updated
- 2025-11-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05842343. Inclusion in this directory is not an endorsement.